Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression

Open access
Cole, Adam R., Noble, Wendy, Aalten, Lidy van, Plattner, Florian, Meimaridou, Rena, Hogan, Dale, Taylor, Margaret, LaFrancois, John, Gunn‐Moore, Frank, Verkhratsky, Alex, Oddo, Salvatore, LaFerla, Frank, Giese, K. Peter, Dineley, Kelly T., Duff, Karen, Richardson, Jill C., Yan, Shi Du, Hanger, Diane P., Allan, Stuart M., Sutherland, Calum · 2007 · Journal of Neurochemistry

Abstract

Collapsin response mediator protein 2 (CRMP2) is an abundant brain‐enriched protein that can regulate microtubule assembly in neurons. This function of CRMP2 is regulated by phosphorylation by glycogen synthase kinase 3 (GSK3) and cyclin‐dependent kinase 5 (Cdk5). Here, using novel phosphospecific antibodies, we demonstrate that phosphorylation of CRMP2 at Ser522 (Cdk5‐mediated) is increased in Alzheimer’s disease (AD) brain, while CRMP2 expression and phosphorylation of the closely related isoform CRMP4 are not altered. In addition, CRMP2 phosphorylation at the Cdk5 and GSK3 sites is increased in cortex and hippocampus of the triple transgenic mouse [presenilin‐1 (PS1)M146V KI; Thy1.2‐amyloid precursor protein (APP)swe; Thy1.2tau P301L] that develops AD‐like plaques and tangles, as well as the double (PS1 M146V KI; Thy1.2‐APP swe) transgenic mouse. The hyperphosphorylation is similar in magnitude to that in human AD and is evident by 2 months of age, ahead of plaque or tangle formation. Meanwhile, there is no change in CRMP2 phosphorylation in two other transgenic mouse lines that display elevated amyloid β peptide levels (Tg2576 and APP/amyloid β‐binding alcohol dehydrogenase). Similarly, CRMP2 phosphorylation is normal in hippocampus and cortex of Tau(P301L) mice that develop tangles but not plaques. These observations implicate hyperphosphorylation of CRMP2 as an early event in the development of AD and suggest that it can be induced by a severe APP over‐expression and/or processing defect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2007.04829.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 168

Metadata

Authors
Cole, A. R., Noble, W., Aalten, L. V., Plattner, F., Meimaridou, R., Hogan, D., Taylor, M., LaFrancois, J., Gunn‐Moore, F., Verkhratsky, A., Oddo, S., LaFerla, F., Giese, K. P., Dineley, K. T., Duff, K., Richardson, J. C., Yan, S. D., Hanger, D. P., Allan, S. M., & Sutherland, C.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2007-07-17
Volume
103
Issue
3
Pages
1132-1144
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2053880389
Cited by
168
References
7
FWCI
3.76
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression. https://app.cochat.ai/papers/10.1111/j.1471-4159.2007.04829.x
The paper
Cole, A. R., Noble, W., Aalten, L. V., Plattner, F., Meimaridou, R., Hogan, D., Taylor, M., LaFrancois, J., Gunn‐Moore, F., Verkhratsky, A., Oddo, S., LaFerla, F., Giese, K. P., Dineley, K. T., Duff, K., Richardson, J. C., Yan, S. D., Hanger, D. P., Allan, S. M., & Sutherland, C. (2007). Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2007.04829.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.